A detailed history of Gladstone Institutional Advisory LLC transactions in Veru Inc. stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 56,876 shares of VERU stock, worth $32,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,876
Previous 42,376 34.22%
Holding current value
$32,988
Previous $35,000 22.86%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$0.77 - $1.04 $11,165 - $15,080
14,500 Added 34.22%
56,876 $43,000
Q2 2024

Aug 02, 2024

BUY
$0.76 - $1.79 $7,885 - $18,573
10,376 Added 32.43%
42,376 $35,000
Q1 2024

May 14, 2024

BUY
$0.37 - $0.72 $11,840 - $23,040
32,000 New
32,000 $22,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.